Vimarsana
Biggest News Aggregation in the World

Page 28 - Jay Olson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jay Olson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jay Olson Today - Breaking & Trending Today

Intellia Therapeutics, Inc. (NTLA) Q1 2021 Earnings Call Transcript - Vimarsana News

Intellia Therapeutics, Inc. (NTLA) Q1 2021 Earnings Call Transcript

Operator Good morning. My name is Izzy and I will be your conference operator today. Welcome to the Intellia Therapeutics First Quarter 2021 Financial Results Conference Call. [Operator Instructions] [Operator Instructions]. Following formal remarks, we will open the call up for questions. This conference is being recorded at the company's request and will be available on the company's website following the end of the call. I will now turn the conference to Lina Li, Director of Investor Relations at Intellia. Please proceed. Lina Li -- Director, Investor Relations Thank you, operator. And Go...

Source: fool.com
Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript - Vimarsana News

Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript

Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Neurocrine Biosciences Inc (NASDAQ: NBIX) Popular Searches Operator Good day, everyone, and welcome to today's Neurocrine Biosciences Reports First Quarter Results. [Operator Instructions] It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla. Please go ahead.SPONSORED: 10 stocks we like better than Neurocrine Biosciences When investing geniuses David and Tom Gardner have a ...

Source: msn.com
Editas Medicine, Inc. (EDIT) Q1 2021 Earnings Call Transcript - Vimarsana News

Editas Medicine, Inc. (EDIT) Q1 2021 Earnings Call Transcript

Operator Good day and thank you for standing by. Welcome to the Q1 2021 Editas Medicine Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] I would now like to hand the conference over to your first speaker today, Ron Moldaver, Investor Relations. Please go ahead. Ron Moldaver -- Investor Relations Thank you, Julian. Good morning, everyone, and welcome to our first quarter 2021 conference call. Earlier this morning, we issued a press release providing our financial results and corporate updates for the first quarter of 2021. A replay of...

Source: fool.com
Incyte Corp (INCY) Q1 2021 Earnings Call Transcript - Vimarsana News

Incyte Corp (INCY) Q1 2021 Earnings Call Transcript

Incyte Corp (INCY) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Incyte Corp (NASDAQ: INCY) Operator Hello and welcome to the Incyte's First Quarter Earnings Call. [Operator Instructions] It's now my pleasure to turn the call over to Christine Chiou. Please go ahead.SPONSORED: 10 stocks we like better than Incyte When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the m...

Source: msn.com
Seattle Genetics (SGEN) Q1 2021 Earnings Call Transcript - Vimarsana News

Seattle Genetics (SGEN) Q1 2021 Earnings Call Transcript

Seattle Genetics (SGEN) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Seattle Genetics (NASDAQ: SGEN) Good day and welcome to Seagen first-quarter 2021 financial results conference call. [Operator instructions] After today's presentation, there will be an opportunity to ask questions. Please note, this event is being recorded. I would now like to turn the conference over to Peggy Pinkston, senior vice president of investor relations. Please go ahead. Senior Vice President of Investor Relations Thank you,...

Source: msn.com